Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity.
Quesada-Vázquez S, Castells-Nobau A, Latorre J, Oliveras-Cañellas N, Puig-Parnau I, Tejera N, Tobajas Y, Baudin J, Hildebrand F, Beraza N, Burcelin R, Martinez-Gili L, Chilloux J, Dumas ME, Federici M, Hoyles L, Caimari A, Del Bas JM, Escoté X, Fernández-Real JM, Mayneris-Perxachs J.
Quesada-Vázquez S, et al. Among authors: escote x.
Cell Rep Med. 2023 Dec 19;4(12):101341. doi: 10.1016/j.xcrm.2023.101341.
Cell Rep Med. 2023.
PMID: 38118419
Free PMC article.